Among these transcripts, DIS3L is a reported ZFX target transcript [8]; additionally, SMO and HOXB5 are reported to regulate CML and normal stem/progenitor cells [50–52]. Here, ZFX is linked to chronic myelogenous leukemia, BCR-ABL1 positive.